![]() |
|
||||
| |
|
||||
| |
|||||
|
|
|||||
|
|
|
|
||
| |
|
|
Who is Scott Mittelstadt? A Lifetime of Sports and Physiology
Sports and School He chose to go to the University of Northern Iowa for his Master’s degree, primarily due to the fact that it was in his home town of Cedar Falls, Iowa and he was familiar with some of the faculty. He knew that Dr. Forrest Dolgener was interested in research on long-distance running and felt that Dr. Dolgener would be a good person to help him begin to understand the research process. Scott’s goal was always to finish his Master’s and then continue his graduate education at another school. At the University of Northern Iowa, Scott was given the opportunity to spend a large amount of time in a “real” laboratory. Since all of the research conducted in that lab was on human subjects, the graduate students were able to try out new techniques using each other as subjects. Scott then chose to go to the University of Missouri for his Ph.D. work because Dr. Ben Londeree had conducted a number of studies regarding distance running performance that Scott found interesting. During his first 2 years in Missouri, Scott was involved in a number of studies investigating performance in distance runners and cyclists. As he began to develop some of his research questions, it became clear that it was going to be difficult to answer these questions in humans. At about that time, Scott attended a seminar by Dr. Harold Laughlin (also at the University of Missouri) who described techniques he used to assess the exercise response in rats. He was willing to let Scott work in his lab to learn those techniques. Scott ended up conducting his dissertation research in that lab. During his time working in Dr. Laughlin’s lab, Scott was exposed to a lot of basic research that was not related necessarily to exercise. After completing his dissertation, Dr. Mittelstadt wanted to continue his training in research on the control of the cardiovascular system. He chose a post-doctoral fellowship at the Medical College of Wisconsin with Drs. Phil Clifford and Leonard Bell. His experience there was a great learning experience because it allowed him to continue learning about research in chronically instrumented animals (now he was working in dogs) and continue conducting research on exercise performance in endurance athletes (cross-country skiers). Working at a Pharmaceutical CompanyAfter his postdoctoral training was finished, Dr. Mittelstadt was hired by Procter & Gamble Pharmaceuticals to conduct pharmacology studies investigating the cardiovascular effects of drugs in pre-clinical models. The techniques he used were techniques that he learned during graduate school and his post-doctoral fellowship. At the present time Dr. Mittelstadt works with a group of other scientists. The group conducts Safety Pharmacology studies. Safety Pharmacology studies are studies that investigate the potential undesirable pharmacological effects of a drug on physiological function. The major organ systems they study are the cardiovascular, respiratory, and central nervous systems. In addition, Dr. Mittelstadt designs pre-clinical safety programs to support the clinical development of drugs. The studies he helps plan include short-term, long-term, reproductive, and genetic toxicity studies. The multi-organ system physiology that he learned as an exercise physiologist is very helpful as he tries to integrate data from many types of studies into an integrated conclusion. Outside ActiviesDr. Mittelstadt enjoys watching all sports. He likes to run, hike, bike, and play golf. He is also active leading classes and community activities at his church.
Advice for Postdoctoral Fellows
1. Mittelstadt, S.W., K.P. O'Hagan, L.B. Bell, and P.S. Clifford. Intrapericardial blocking agents have extra-cardiac effects in dogs. Am. J. Physiol. Regulatory Integrative Physiol. 266: R1970-R1975, 1994. 2. Mittelstadt, S.W., L.B. Bell, K.P. O'Hagan, and P.S. Clifford. Muscle chemoreflex alters vascular conductance in nonischemic exercising skeletal muscle. J. Appl. Physiol. 77:2761-2766, 1994. 3. O'Hagan, K.P., R.S. Anderson, L.B. Bell, S.W. Mittelstadt, and P.S. Clifford. Phenylbiguanide does not inhibit locomotion in conscious rabbits. J. Appl. Physiol. 79:1346-1350, 1995. 4. Mittelstadt, S.W., L.B. Bell, K.P. O'Hagan, J.E. Sulentic, and P.S. Clifford. Muscle chemoreflex causes renal vascular constriction. Am. J. Physiol. Heart Circ. Physiol. 270: H951-H956, 1996. 5. Mittelstadt, S.W., A.E. Maynard, D.R. Benn, E.R. Lowe, and D.R. Kostreva. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats. Cardiovasc. Drugs Ther. 11: 591-598, 1997. 6. Hamlin, R.D., C.A. Cruze, S.W. Mittelstadt, A. Kijtawornrat, B.W. Keene, B.M. Roche, T. Nakayama, H. Nakayama, and D.M. Hamlin. Sensitivity and specificity of isolated perfused guinea pig heart to test for drug-induced lengthening of QTc. J. Pharmacol. Toxicol. Methods 49: 15-23, 2004.
|
|